Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Challenges of establishing new antithrombotic therapies in atrial fibrillation.

× No keyword cloud information.

11 in total

Review 1. Assessing Patient Management and Outcomes in Atrial Fibrillation: Does your Health Insurance Plan know more than your Doctor?

Authors: Sanjeev Saksena; April Slee
Journal: J Atr Fibrillation Date: 2009-04-01

2. New anticoagulants in atrial fibrillation: an update for clinicians.

Authors: Satjit Bhusri; Jack Ansell
Journal: Ther Adv Chronic Dis Date: 2012-01 Impact factor: 5.091

Review 3. Stroke prevention in atrial fibrillation: putting the guidelines into practice.

Authors: Jonathan Mant; Duncan Edwards
Journal: Drugs Aging Date: 2010-11-01 Impact factor: 3.923

Review 4. Atrial Fibrillation: The New Epidemic of the Ageing World.

Authors: Wilbert S Aronow; Maciej Banach
Journal: J Atr Fibrillation Date: 2009-04-01

Review 5. The future of inpatient anticoagulation management.

Authors: Allison E Burnett; Toby C Trujillo
Journal: J Thromb Thrombolysis Date: 2013-04 Impact factor: 2.300

6. Dietary Fat Intake Is Differentially Associated with Risk of Paroxysmal Compared with Sustained Atrial Fibrillation in Women.

Authors: Stephanie E Chiuve; Roopinder K Sandhu; M Vinayaga Moorthy; Robert J Glynn; Christine M Albert
Journal: J Nutr Date: 2015-07-15 Impact factor: 4.798

7. Dabigatran: a new anticoagulant for stroke prevention in patients with atrial fibrillation.

Authors: Richard Weachter
Journal: Mo Med Date: 2012 Mar-Apr

Review 8. Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.

Authors: Alessandro Blandino; Francesca Bianchi; Giuseppe Biondi-Zoccai; Stefano Grossi; Maria Rosa Conte; Francesco Rametta; Fiorenzo Gaita
Journal: J Interv Card Electrophysiol Date: 2016-05-23 Impact factor: 1.900

Review 9. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.

Authors: Karsten Mh Bruins Slot; Eivind Berge
Journal: Cochrane Database Syst Rev Date: 2018-03-06

10. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.

Authors: Gregory Y H Lip; Lars H Rasmussen; S Bertil Olsson; Eva C Jensen; Anders L Persson; Ulf Eriksson; Karin F C Wåhlander
Journal: Eur Heart J Date: 2009-08-18 Impact factor: 29.983